Gene · 638
Papers2,521
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
121 to 140 of 2,521
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Reactive oxygen species mediated apoptotic death of colon cancer cells: therapeutic potential of plant derived alkaloids. | Front Endocrinol (Lausanne) | 2023 | 37560308 | PubTator, text mining | PubMed |
| Structural basis of the specificity and interaction mechanism of Bmf binding to pro-survival Bcl-2 family proteins. | Comput Struct Biotechnol J | 2023 | 37560128 | PubTator, text mining | PubMed |
| Valosin containing protein (VCP): initiator, modifier, and potential drug target for neurodegenerative diseases. | Mol Neurodegener | 2023 | 37545006 | PubTator, text mining | PubMed |
| Spatial tumour gene signature discriminates neoplastic from non-neoplastic compartments in colon cancer: unravelling predictive biomarkers for relapse. | J Transl Med | 2023 | 37543577 | PubTator, text mining | PubMed |
| BCLXL PROTAC degrader DT2216 targets secondary plasma cell leukemia addicted to BCLXL for survival. | Front Oncol | 2023 | 37534243 | PubTator, text mining | PubMed |
| Differentiation of neurosphere after transplantation into the damaged spinal cord. | J Med Life | 2023 | 37520471 | PubTator, text mining | PubMed |
| Involvement of Both Extrinsic and Intrinsic Apoptotic Pathways in Tridecylpyrrolidine-Diol Derivative-Induced Apoptosis In Vitro. | Int J Mol Sci | 2023 | 37511455 | PubTator, text mining | PubMed |
| Activity Changes of the Peptic Lactoferrin Hydrolysate in Human Gastric Cancer AGS Cells in Response to Cu(II) or Mn(II) Addition. | Foods | 2023 | 37509754 | PubTator, text mining | PubMed |
| NOXA Accentuates Apoptosis Induction by a Novel Histone Deacetylase Inhibitor. | Cancers (Basel) | 2023 | 37509312 | PubTator, text mining | PubMed |
| State of the Art of Pharmacological Activators of p53 in Ocular Malignancies. | Cancers (Basel) | 2023 | 37509256 | PubTator, text mining | PubMed |
| The Synergistic Antitumor Effect of Decitabine and Vorinostat Combination on HepG2 Human Hepatocellular Carcinoma Cell Line via Epigenetic Modulation of Autophagy-Apoptosis Molecular Crosstalk. | Curr Issues Mol Biol | 2023 | 37504291 | PubTator, text mining | PubMed |
| MDM2 inhibition is synthetic lethal with PTEN loss in colorectal cancer cells via the p53-dependent mechanism. | Int J Biol Sci | 2023 | 37496993 | PubTator, text mining | PubMed |
| In silico identification and in vitro assessment of a potential anti-breast cancer activity of antimicrobial peptide retrieved from the ATMP1 Anabas testudineus fish peptide. | PeerJ | 2023 | 37483971 | PubTator, text mining | PubMed |
| SLE Antibody-Secreting Cells Are Characterized by Enhanced Peripheral Maturation and Survival Programs. | Res Sq | 2023 | 37461641 | PubTator, text mining | PubMed |
| GSK-3 Inhibitor Elraglusib Enhances Tumor-Infiltrating Immune Cell Activation in Tumor Biopsies and Synergizes with Anti-PD-L1 in a Murine Model of Colorectal Cancer. | Int J Mol Sci | 2023 | 37446056 | PubTator, text mining | PubMed |
| An Emerging Role for Sigma Receptor 1 in Personalized Treatment of Breast Cancer. | Cancers (Basel) | 2023 | 37444574 | PubTator, text mining | PubMed |
| Single-cell RNA sequencing reveals enhanced antitumor immunity after combined application of PD-1 inhibitor and Shenmai injection in non-small cell lung cancer. | Cell Commun Signal | 2023 | 37430270 | PubTator, text mining | PubMed |
| Targeting histone deacetylases for cancer therapy: Trends and challenges. | Acta Pharm Sin B | 2023 | 37425042 | PubTator, text mining | PubMed |
| Arginine regulates HSPA5/BiP translation through ribosome pausing in triple-negative breast cancer cells. | Br J Cancer | 2023 | 37386138 | PubTator, text mining | PubMed |
| Neuronal Responses to Ischemia: Scoping Review of Insights from Human-Derived In Vitro Models. | Cell Mol Neurobiol | 2023 | 37380886 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/638/papers?page=7